ロード中...
CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity
The prognosis of patients with acute myeloid leukemia (AML) remains dismal, highlighting the need for novel innovative treatment strategies. The application of chimeric antigen receptor (CAR) T-cell therapy to patients with AML has been limited, in particular by the lack of a tumor-specific target a...
保存先:
| 出版年: | Blood |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Hematology
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8323977/ https://ncbi.nlm.nih.gov/pubmed/34323938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020008221 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|